Integrated Filing — IndAS



General information about company
Scrip Code 000000
NSE Symbol OSWALSEEDS
MSEI Symbol NOTLISTED
ISIN INE00IK01029
Name of company SHREEOSWAL SEEDS AND CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Processing of Seeds
Start date and time of board meeting 30-May-2025   17:30:00
End date and time of board meeting 30-May-2025   20:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-14
Indicate Company website link for updated RPT policy of the Company https://www.oswalseeds.com/files/Policy/related%20party%20policy_Oswal_14.02.2025.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default on loan and debt securities hence disclosure is not applicable on the Company.



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 12960000 972140000
Other income 3891000 21017000
Total income 16851000 993157000
2 Expenses
(a) Cost of materials consumed 239458000 959368000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -222763000 -61873000
(d) Employee benefit expense 8579000 25736000
(e) Finance costs 2907000 10615000
(f) Depreciation, depletion and amortisation expense 908000 3730000
(f) Other Expenses
1  Other expenses 5234000 15718000
Total other expenses 5234000 15718000
Total expenses 34323000 953294000
3 Total profit before exceptional items and tax -17472000 39863000
4 Exceptional items 0 0
5 Total profit before tax -17472000 39863000
6 Tax expense
7 Current tax -4244000 11748000
8 Deferred tax -336000 -371000
9 Total tax expenses -4580000 11377000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations -12892000 28486000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period -12892000 28486000
17 Other comprehensive income net of taxes -43000 -43000
18 Total Comprehensive Income for the period -12935000 28443000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 182940000 182940000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 260576000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.14 0.31
Diluted earnings (loss) per share from continuing operations -0.14 0.31
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.14 0.31
Diluted earnings (loss) per share from continuing and discontinued operations -0.14 0.31
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) NOTES: n n1. The above Audited standalone and consolidated financial results for the quarter and year ended March 31st, 2025 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in its meeting held on 30th May, 2025. The above results have been audited by Statutory Auditors of the Company interms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, who have expressed an unmodified opinion. n n2. The above Audited standalone and consolidated financial results have been prepared in accordance with the guidelines issued by the Securities and Exchange Board of India (SEBI) and the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act and other recognized accounting practices and policies to the extent applicable. n n3. The above consolidated financial results include the result of Wholly Owned Subsidiary Company i.e. Shreeoswal Psyllium Exports India Limited. n n4. The Company has no reportable segment on standalone basis and on consolidated basis the Company has two reportable segments which consist of Seed and Psyllium in accordance with Ind AS-108 Operating Segment. n n5. Figures for the previous / year have been rearranged/regrouped, restated, reclassified and/or recasted wherever considered necessary to correspond with the figures of the Current period / Year. All figures of financials have been rounded off to nearest Lakhs Rupees. n n6. The Statement includes the results for the quarters ended March 31, 2025 and March 31, 2024 and being the balancing figure of the audited figures in respect of the full financial year and the published year to date figures upto the third quarter of the respective financial years, the results of which were subjected to ‘limited review’. n n7. The Statement of Assets & Liabilities as at March 31, 2025 is annexed with the results along with the Statement of Cash Flow.. n n8. The aforesaid Audited standalone and consolidated Financial Results will be uploaded on the Company's website http://www.oswalseeds.com and will also be available on the website of the NSE www.nseindia.com for the benefit of shareholders and investors. n n FOR SHREEOSWAL SEEDS AND CHEMICALS LIMITED n n n Sanjay Kumar Begani n Chairman & Managing Director nDate: 30th May, 2025tt DIN: 07921083 nPlace: Neemuch



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 39080000
Capital work-in-progress 15157000
Investment property 0
Goodwill 0
Other intangible assets 0
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 200073000
Trade receivables, non-current 0
Loans, non-current 75884000
Other non-current financial assets 5586000
Total non-current financial assets 281543000
Deferred tax assets (net) 1920000
Other non-current assets 0
Total non-current assets 337700000
2 Current assets
Inventories 238899000
Current financial asset
Current investments 0
Trade receivables, current 36121000
Cash and cash equivalents 1113000
Bank balance other than cash and cash equivalents 0
Loans, current 129000
Other current financial assets 1276000
Total current financial assets 38639000
Current tax assets (net) 1833000
Other current assets 75635000
Total current assets 355006000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 692706000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 182940000
Other equity 260576000
Total equity attributable to owners of parent 443516000
Non controlling interest
Total equity 443516000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1842000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 6088000
Total non-current financial liabilities 7930000
Provisions, non-current 4773000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 530000
Total non-current liabilities 13233000
Current liabilities
Current financial liabilities
Borrowings, current 102989000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 3622000
Total Trade payable 3622000
Other current financial liabilities 0
Total current financial liabilities 106611000
Other current liabilities 129081000
Provisions, current 265000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 235957000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 249190000
Total equity and liabilites 692706000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 (I) Items that will not be reclassified to Profit or Loss -59000 -59000
Total Amount of items that will not be reclassified to profit and loss -59000 -59000
2 Income tax relating to items that will not be reclassified to profit or loss -16000 -16000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -43000 -43000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 39863000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 10615000
Adjustments for decrease (increase) in inventories -46637000
Adjustments for decrease (increase) in trade receivables, current 48691000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -56733000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current -1254000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 2698000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -32952000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 3730000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 713000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 71000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -18754000
Other adjustments to reconcile profit (loss) 53000
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -89759000
Net cash flows from (used in) operations -49896000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 4363000
Other inflows (outflows) of cash -91000
Net cash flows from (used in) operating activities -54350000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 1843000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 63501000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 15240000
Net cash flows from (used in) investing activities 76898000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 1842000
Repayments of borrowings 31358000
Payments of lease liabilities 0
Dividends paid 0
Interest paid 10021000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -39537000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -16989000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -16989000
Cash and cash equivalents cash flow statement at beginning of period 18102000
Cash and cash equivalents cash flow statement at end of period 1113000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 J C Baheti & Associates Yes 31-Aug-2027


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. wholly owned subsidiary company Loan 0 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 43639000 238421000 75884000 Loan 0.1 NA Unsecured Business operation (Loan Given)
2 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. wholly owned subsidiary company Interest received 0 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 7725000 0 0
3 SHREEOSWAL SEEDS & CHEMICALS LTD. SANJAY KUMAR BEGANI CHAIRMAN & MANAGING DIRECTOR Remuneration 9000000 As Approved by Audit Committee and members of the company 4050000 400000 0
4 SHREEOSWAL SEEDS & CHEMICALS LTD. ANIL KUMAR NAHTA WHOLETIME DIRECTOR & CEO Remuneration 9000000 As Approved by Audit Committee and members of the company 4050000 400000 0
5 SHREEOSWAL SEEDS & CHEMICALS LTD. DILIP PATIDAR Company Secretary Cum Comliance Officer Remuneration 500000 As Approved by Audit Committee 180000 30000 0
6 SHREEOSWAL SEEDS & CHEMICALS LTD. ASHOK DHAKAR CFO Remuneration 500000 As Approved by Audit Committee 223000 32000 0
7 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. wholly owned subsidiary company Any other transaction RENT PAID 360000 As Approved by Audit Committee 180000 0 0
8 SHREEOSWAL SEEDS & CHEMICALS LTD. GOPAL AGARWAL INDEPENDENT DIRECTOR Any other transaction Outstanding Sitting Fees 0 NA 0 45000 45000
9 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. KIRAN DEVI BEGANI WHOLE TIME DIRECTOR Remuneration 2400000 As Approved by Audit Committee 900000 130000 0
10 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. PADMA NAHTA WHOLE TIME DIRECTOR Remuneration 2400000 As Approved by Audit Committee 900000 130000 0
11 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SANJAY KUMAR BEGANI NON- EXECUTIVE DIRECTOR Loan 100000000 As Approved by Audit Committee 23000000 8200000 0 Textual Information(1)
12 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. ANIL KUMAR NAHTA NON- EXECUTIVE DIRECTOR Loan 100000000 As Approved by Audit Committee 17550000 9400000 0 Textual Information(2)
13 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SHREEOSWAL SEEDS & CHEMICALS LTD. HOLDING COMPANY Any other transaction RENT PAID 720000 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 360000 0 0
14 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. wholly owned subsidiary company Investment 0 NA 0 200000000 200000000
15 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction CORPORATE GUARANTEE 1100000000 As Approved by Audit Committee and members of the company 0 0 1100000000
16 SHREEOSWAL SEEDS & CHEMICALS LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction CORPORATE GUARANTEE 1100000000 As Approved by Audit Committee and members of the company 0 0 1100000000
17 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. DILIP PATIDAR Company Secretary Cum Comliance Officer Remuneration 200000 As Approved by Audit Committee 90000 15000 0
18 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. ACHARYA KUMAR JAIN CFO Remuneration 400000 As Approved by Audit Committee 195000 24000 0
19 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction CORPORATE GUARANTEE 1100000 As Approved by Audit Committee 1100000 0 0
20 SHREEOSWAL SEEDS & CHEMICALS LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction CORPORATE GUARANTEE 1100000 As Approved by Audit Committee 1100000 0 0
21 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SHREEOSWAL SEEDS & CHEMICALS LTD. HOLDING COMPANY Any other transaction Repayment of Loan 0 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 213650000 238421000 75884000 Loan 0.1 NA Unsecured Business operation (Loan Taken)
Total value of transaction during the reporting period 318892000



Text Block
Textual Information(1) No Interest Charged
Textual Information(2) No Interest Charged